Your browser doesn't support javascript.
loading
US-triggered ultra-sensitive "thrombus constructor" for precise tumor therapy.
Shao, Yanjiang; Guo, Li; Li, Airong; Zhang, Kaixiang; Liu, Wei; Shi, Jinjin; Liu, Junjie; Zhang, Zhenzhong.
Afiliación
  • Shao Y; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, PR China; Collaborative Innovation Center of New Drug Research and Safety Evaluation, Henan Province, PR China; Key laboratory of Targeting Therapy and Diagnosis for Critical Diseases, Henan Province, PR China.
  • Guo L; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, PR China; Collaborative Innovation Center of New Drug Research and Safety Evaluation, Henan Province, PR China; Key laboratory of Targeting Therapy and Diagnosis for Critical Diseases, Henan Province, PR China.
  • Li A; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, PR China.
  • Zhang K; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, PR China; Collaborative Innovation Center of New Drug Research and Safety Evaluation, Henan Province, PR China; Key laboratory of Targeting Therapy and Diagnosis for Critical Diseases, Henan Province, PR China.
  • Liu W; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, PR China; Collaborative Innovation Center of New Drug Research and Safety Evaluation, Henan Province, PR China; Key laboratory of Targeting Therapy and Diagnosis for Critical Diseases, Henan Province, PR China.
  • Shi J; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, PR China; Collaborative Innovation Center of New Drug Research and Safety Evaluation, Henan Province, PR China; Key laboratory of Targeting Therapy and Diagnosis for Critical Diseases, Henan Province, PR China. Electronic address: s
  • Liu J; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, PR China; Collaborative Innovation Center of New Drug Research and Safety Evaluation, Henan Province, PR China; Key laboratory of Targeting Therapy and Diagnosis for Critical Diseases, Henan Province, PR China. Electronic address: l
  • Zhang Z; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, PR China; Collaborative Innovation Center of New Drug Research and Safety Evaluation, Henan Province, PR China; Key laboratory of Targeting Therapy and Diagnosis for Critical Diseases, Henan Province, PR China. Electronic address: z
J Control Release ; 318: 136-144, 2020 02.
Article en En | MEDLINE | ID: mdl-31862357
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trombosis / Neoplasias Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Revista: J Control Release Asunto de la revista: FARMACOLOGIA Año: 2020 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trombosis / Neoplasias Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Revista: J Control Release Asunto de la revista: FARMACOLOGIA Año: 2020 Tipo del documento: Article